Drug Discov Ther. 2011;5(4):159-161. (DOI: 10.5582/ddt.2011.v5.4.159)

Prospects for using pre-exposure prophylaxis to control the prevalence of HIV/AIDS in China.

Xue QY, Gao JJ, Song PP, Qu XJ, Xu LZ


Although important progress has been achieved in combating HIV/AIDs over the past 30 years, HIV/AIDs is still a serious threat to today's world. In China, figures on the incidence of this disease have painted a less than optimistic outlook. As the prevailing methods of preventing HIV/AIDS are all partially effective, novel and effective preventive interventions are needed in order to control the spread of the disease. Pre-exposure prophylaxis (PrEP) is one of the most promising prevention strategies and has garnered great attention worldwide. Current clinical trials on the efficacy and safety of this strategy have had some favorable results though major challenges around the world remain. Thus, China has taken an active part in the PrEP study to limit the prevalence of HIV/AIDS. This article describes the status of the PrEP study and discusses the opportunities and challenges encountered when implementing this strategy in China.

KEYWORDS: Pre-exposure Prophylaxis (PrEP), HIV/AIDS, ethical dilemmas, financial capacity

Full Text: